How many patents does
Nsabp Foundation have?
patents
207
families
16
granted
51
applications
156
US
46
EP
30
WO
9
JP
7
KR
5
CN
5
GB
4
RoW
101
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Nsabp Foundation
Top ten assignees appearing on patents
2009 - 2018
| genomic health | 105 |
| thornton & ross | 48 |
| genentech | 15 |
| thornton and ross | 2 |
2009
| genomic health | 11 |
| thornton & ross | 2 |
2018
| genomic health | 8 |
| thornton & ross | 2 |
Nsabp Foundation
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| gene expression markers for colorectal cancer prognosis | 57 | 2006 |
| a method and composition for the control of ectoparasites | 55 | 2009 |
| prediction of likelihood of cancer recurrence | 23 | 2003 |
| adjuvant cancer therapy | 17 | 2009 |
| expression profile algorithm and test for cancer prognosis | 10 | 2003 |
| molecular indicators of breast cancer prognosis and prediction of treatment response | 9 | 2004 |
| gene expression markers for prediction of patient response to chemotherapy | 6 | 2008 |
| predicting response to chemotherapy using gene expression markers | 6 | 2004 |
| identification and use of prognostic and predictive markers in cancer treatment | 6 | 2008 |
| prediction of likelihood of cancer recurrence | 5 | 2003 |